Redhawk Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Redhawk Wealth Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.76M	Buy	23,790 +3,651	+18%	+$494K	0.37%	71
2026 Q1	$2.57M	Sell	20,139 -3,169	-14%	-$396K	0.28%	87
2025 Q4	$2.84M	Buy	+23,308	New	+$2.67M	0.32%	84
2019 Q3	–	Sell	-3	Closed	–	–	452
2019 Q2	$0	Buy	+3	New	+$256	﹤0.01%	495

Other funds holding XBI

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

PSP Research Newtown Square, Pennsylvania $188M AUM

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

MFS

Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

LHWM

Lake Hills Wealth Management Austin, Texas $220M AUM 39.11% 1-Year Est. Return

MWA

MFA Wealth Advisors Pittsburgh, Pennsylvania $587M AUM 27.44% 1-Year Est. Return

Parkside Investments Deerfield, Illinois $902M AUM 32.45% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

MAM

Marotta Asset Management Charlottesville, Virginia $601M AUM 21.35% 1-Year Est. Return

Redhawk Wealth Advisors's XBI Position: Q2 2026 in Review

Redhawk Wealth Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 18% in Q2 2026, buying an estimated $494K and bringing the position to 23,790 shares worth $3.76M. The position accounts for 0.37% of the portfolio, ranked #71.

Redhawk Wealth Advisors first reported a position in XBI in Q2 2019 and has held it in 4 quarters since. 132 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Redhawk Wealth Advisors held 23,790 shares of State Street SPDR S&P Biotech ETF worth $3.76M as of Q2 2026.
Redhawk Wealth Advisors bought 3,651 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $494K.
State Street SPDR S&P Biotech ETF made up 0.37% of Redhawk Wealth Advisors's portfolio in Q2 2026, its #71 holding.
Redhawk Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2019 and has held it in 4 quarters since.
132 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.